Cardiologs

Cardiovascular disease is the first cause of premature death in the world. Arrhythmia is a set of heart conditions affecting tens of millions of people worldwide in which the heart beats with an abnormal rhythm, leading to symptoms such as syncope, palpitations, and stroke. It is crucial to diagnose an arrhythmia and start treatment before tragic consequences happen. The most common exam to diagnose an arrhythmia is an ambulatory electrocardiogram (ECG), which records the electrical activity of the heart between 1 and 30 days, and even up to a few years in the case of implantable devices. The vast amounts of data generated by such tests still require experts to go through a time-consuming and labor-intensive process, resulting in elevated costs, treatment delays, and variable quality. Cardiologs is on a mission to democratize access to expert cardiac care through medical-grade artificial intelligence and cloud technology. Founded in 2014, Cardiologs provides a cloud-based solution powered by a medical-grade AI. Cardiologs is the world’s first medical device powered by deep learning, to have received regulatory clearance (CE Mark in August 2016). It is also among the first to have received FDA clearance (June 2017). Cardiologs is commercialized in the US and France and plans to accelerate growth in the rest of Europe in 2021. Cardiologs is a tight-knit team of more than 60 people, based between Boston, USA, and Paris, France.